Fidelity International High Dividend ETF (FIDI): outlook, holdings and fees
Fidelity International High Dividend ETF (FIDI) is an exchange-traded fund and is managed by Fidelity Investments. The expense ratio is 0.17% and the yield is 4.46%. The ten largest holdings are 28% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on FIDI
| Last price | $29.02 (+0.2%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 57% |
| Likely 1-month range (50%) | $28.59 – $29.77 |
| Normal 1-day range (±1σ) | ±0.7% |
| Distribution yield | 4.46% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
FIDI fund facts
| Issuer | Fidelity Investments |
|---|---|
| Theme | International developed |
| Assets under management | $390M |
| Expense ratio | 0.17% |
| Number of holdings | 50 |
| Portfolio turnover | 68% |
| Inception | Jan 16, 2018 |
| Exchange | NYSE |
The fund normally invests at least 80% of assets in securities included in the Fidelity ® International High Dividend Index and in depositary receipts representing securities included in the index. The index is designed to reflect the performance of stocks of large- and mid-capitalization developed international high dividend-paying companies that are expected to continue to pay and grow their dividends.
FIDI top holdings
| Holding | Sector | Weight |
|---|---|---|
| Equinor ASA EQNR | Energy | 4.15% |
| TotalEnergies SE ADR TTE | Energy | 3.56% |
| Canadian Natural Resources Ltd CNQ | Energy | 3.13% |
| Klepierre SA LI | Real Estate | 2.66% |
| Japan Tobacco Inc 2914 | Consumer Defensive | 2.47% |
| Woodside Petroleum Ltd WPL | Energy | 2.47% |
| Nestle S.A. NESN | Consumer Defensive | 2.41% |
| Daito Trust Construction 1878 | Real Estate | 2.49% |
| Link Real Estate Investment Trust 0823 | Real Estate | 2.44% |
| Naturgy Energy Group SA NTGY | Utilities | 2.40% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
FIDI sector breakdown
| Sector | Weight |
|---|---|
| Financial Services | 21.6% |
| Energy | 16.7% |
| Consumer Defensive | 13.7% |
| Industrials | 11.9% |
| Consumer Cyclicals | 11.0% |
| Utilities | 10.9% |
| Real Estate | 8.7% |
| Healthcare | 2.4% |
| Technology | 1.8% |
| Basic Materials | 1.4% |
By region: Europe Developed 41.3%, Japan 20.5%, North America 14.2%, Australasia 10.0%, United Kingdom 9.6%.
FIDI returns and risk
| Year to date | +12.8% |
|---|---|
| 1 year | +21.7% |
| 3 years (annualised) | +20.9% |
| 5 years (annualised) | +11.7% |
| 10 years (annualised) | 0.0% |
| Volatility (3 years) | 12.6% |
| Sharpe ratio (3 years) | 1.27 |
Past returns do not guarantee future results.
FIDI: frequently asked questions
What does FIDI invest in?
Fidelity International High Dividend ETF invests in a portfolio of securities. Its largest holdings are Equinor ASA (4.2%), TotalEnergies SE ADR (3.6%), Canadian Natural Resources Ltd (3.1%), Klepierre SA (2.7%), Japan Tobacco Inc (2.5%).
What is the FIDI expense ratio?
0.17% a year: about $17.00 for every $10,000 invested.
What is the FIDI dividend yield?
4.46%. ATLAS does not hold the exact distribution dates for ETFs.
Will FIDI go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 57%, with a likely range (50%) of $28.59 to $29.77 from $29.02 today. It is a probability, not a prediction.
How has FIDI performed?
Year to date +12.8%, one year +21.7%, three years +20.9% a year, five years +11.7% a year. Past returns do not guarantee future results.
Similar ETFs: International developed
- Vanguard FTSE Developed Markets ETF (VEA)
- iShares Core MSCI EAFE ETF (IEFA)
- Vanguard Total International Stock ETF (VXUS)
- iShares MSCI EAFE ETF (EFA)
- Vanguard FTSE All-World ex-US Index Fund ETF Shares (VEU)
- Schwab International Equity ETF (SCHF)
- iShares Core MSCI Total International Stock ETF (IXUS)
- State Street SPDR Portfolio Developed World ex-US ETF (SPDW)
Educational information, not investment advice. Disclaimer